Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 20:00
Royalty Pharma Total Assets (Quarterly): 18.04B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.04B |
| June 30, 2024 | 17.66B |
| March 31, 2024 | 16.13B |
| December 31, 2023 | 16.38B |
| September 30, 2023 | 15.86B |
| June 30, 2023 | 17.12B |
| March 31, 2023 | 17.07B |
| December 31, 2022 | 16.81B |
| September 30, 2022 | 17.67B |
| June 30, 2022 | 17.74B |
| Date | Value |
|---|---|
| March 31, 2022 | 17.38B |
| December 31, 2021 | 17.52B |
| September 30, 2021 | 17.73B |
| June 30, 2021 | 16.51B |
| March 31, 2021 | 15.91B |
| December 31, 2020 | 16.02B |
| September 30, 2020 | 15.99B |
| June 30, 2020 | 15.69B |
| March 31, 2020 | 13.37B |
| December 31, 2019 | 12.45B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.45B
Minimum
Dec 2019
18.04B
Maximum
Sep 2024
16.45B
Average
16.66B
Median
Total Assets (Quarterly) Benchmarks
| Geron Corp | 444.95M |
| Amicus Therapeutics Inc | 786.56M |
| Ionis Pharmaceuticals Inc | 3.081B |
| Arbutus Biopharma Corp | 140.44M |
| Syndax Pharmaceuticals Inc | 425.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.784B |
| Shareholders Equity (Quarterly) | 6.870B |
| Debt to Equity Ratio | 1.107 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | -0.76% |